TFF Pharmaceuticals Inc (NAS:TFFP)
$ 1.87 0 (0%) Market Cap: 6.48 Mil Enterprise Value: 2.17 Mil PE Ratio: 0 PB Ratio: 1.03 GF Score: 29/100

TFF Pharmaceuticals Inc Science Day Transcript

Dec 13, 2021 / 06:30PM GMT
Release Date Price: $199.75 (+2.04%)
Operator

Good afternoon, and welcome to the TFF Pharmaceutical Science Day. (Operator Instructions)

As a reminder, this webinar is being recorded, and a replay will be made available on the TFF website following the conclusion of the event. I'd now like to turn the call over to your host, Dr. Dale Christensen, TFF Pharmaceuticals Clinical Development Head. Please go ahead, Dale.

Dale Christensen
TFF Pharmaceuticals, Inc. - Director of Clinical Development

Hello. I'd like to thank everybody for joining our call today to hear about the exciting work that TFF has been doing in the development of inhaled voriconazole, as well as our COVID approach with an inhaled antibody that has been partnered with Augmenta Bioworks and Dr. Chris Emig. For formalities, please read the safe harbor statement, and these slides will be online after the call. Again, thank you for joining today. And I would like to give an outline of what the presentation order will be Dr. Schwarz will first present our work on the voriconazole inhalation powder. And then Dr. Emig will speak about the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot